Shenox Pharmaceuticals, LLC   Report issue

For profit Phase 1
Founded: North Brunswick NJ United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2018
NCT03721900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Shenox Pharmaceuticals, LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

ketamine (ketalar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 1)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1